Unibest
← Back to patent-cliff list

CAS 78727-16-9

N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

Codes: TOFA-032

Application context (from source-drug indications)

Ankylosing spondylitisTofacitinib CitrateJuvenile rheumatoid arthritisTofacitinib CitrateUlcerative colitisTofacitinib CitratePsoriatic arthritisTofacitinib CitrateRheumatoid arthritisTofacitinib Citrate

Source drugs (routes using this intermediate)

DrugTierExpiry
Tofacitinib CitrateTier B — Position early2028

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Nantong cGMP Site(3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine HCL
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site4-Chloro-7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works1-benzyl-4-methylpiperidin-3-one
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP SiteN-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.